Complete loss of wild-type TP53 in a nontransformed human epithelial cell line is preceded by a phase during which a heterozygous TP53 mutant effectively outgrows the homozygous wild-type cells

MLA

Kirsten Vang Nielsen, et al. “Complete Loss of Wild-Type TP53 in a Nontransformed Human Epithelial Cell Line Is Preceded by a Phase during Which a Heterozygous TP53 Mutant Effectively Outgrows the Homozygous Wild-Type Cells.” Cancer Genetics and Cytogenetics, vol. 116, no. 1, Jan. 2000. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....d95781726d877890c0fd1793f53fbe83&authtype=sso&custid=ns315887.

APA

Kirsten Vang Nielsen, Per Briand, René Villadsen, & Lars Bolund. (2000). Complete loss of wild-type TP53 in a nontransformed human epithelial cell line is preceded by a phase during which a heterozygous TP53 mutant effectively outgrows the homozygous wild-type cells. Cancer Genetics and Cytogenetics, 116(1).

Chicago

Kirsten Vang Nielsen, Per Briand, René Villadsen, and Lars Bolund. 2000. “Complete Loss of Wild-Type TP53 in a Nontransformed Human Epithelial Cell Line Is Preceded by a Phase during Which a Heterozygous TP53 Mutant Effectively Outgrows the Homozygous Wild-Type Cells.” Cancer Genetics and Cytogenetics 116 (1). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....d95781726d877890c0fd1793f53fbe83&authtype=sso&custid=ns315887.